Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.379SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.240SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.240.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.46SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.44SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.389SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.549SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.160.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.50 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.266SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.253SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.305SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AA.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.241SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.33SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.326SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.255SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.303SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AA.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.173SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.362.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.48SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.36.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.520SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.36.38SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.521SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.383SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.117SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.157SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.187SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.160.30SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.243SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
R.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.216SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.471SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
C.16SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.420SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
L.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.36SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.518SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.551SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
C.17SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.207SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.604SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.111SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.619SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
A.23.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.316SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used